CCL11 and head and neck squamous cell carcinoma: Similarly, high CCL11 expression was associated with lower odds of death for the HNSCC cohort (HR = 0.92, 95% CI 0.82‐0.98, P = .016) and OTSCC subgroup (HR = 0.81, 95% CI 0.70‐0.94, P = .005).